NewsRx

Search our medical news database

Research & Markets

Market report on an influenza pandemic compares available vaccines

Published in Disease Risk Factor Week, April 23rd, 2006

Research and Markets has announced the addition of the Decision Resources report "Is There Commercial Opportunity in the Development of a New Influenza Vaccine'" to its product line.

Influenza is a significant health issue, according to the report. Influenza epidemics occur yearly, and recently, health groups such as the World Health Organization and the U.S. Centers for Disease Control and Prevention have raised the possibility of an influenza pandemic. The U.S. Office of Health and Human Services estimates that, without intervention, a pandemic could cause the deaths of almost 2 million people in the United States and require the hospitalization of up to 10...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Disease Risk Factor Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook